• ECE-1c Stabilization Drives Cisplatin Resistance in Lung Can

  2026-07-09

  Almarza et al. (2024) reveal that stabilization of the ECE-1c isoform enhances stemness, invasiveness, and cisplatin resistance in non–small cell lung cancer (NSCLC) cells via a CK2-dependent, ET-1-independent pathway. These findings propose phospho-ECE-1c as a prognostic biomarker and support CK2 inhibition as a potential therapeutic strategy.

• Novel PDK4 Inhibitors: Metabolic Disease Therapy and Researc

  2026-07-08

  This article examines the discovery of a new class of allosteric PDK4 inhibitors, highlighting compound 8c’s efficacy in metabolic disease, allergy, and cancer models. The findings provide a foundation for targeted therapeutic development and offer valuable methodology for pharmacokinetic and mechanistic studies in metabolic research.

• Hexetidine (NSC-17764): Precision Antibacterial Workflows

  2026-07-08

  Hexetidine (NSC-17764) stands out as a robust broad-spectrum antimicrobial, enabling both reliable biofilm inhibition and targeted oral infection research. This guide translates key comparative findings and protocol nuances into actionable steps for laboratory scientists seeking reproducible, high-impact results.

• HBsAg Suppresses Interferon via TBK1 and Induces Early Autop

  2026-07-07

  The referenced study uncovers how the hepatitis B surface antigen (HBsAg) interacts with TANK-binding kinase 1 (TBK1), suppressing type I interferon production while inducing early autophagy in hepatocytes. This mechanistic insight clarifies HBV’s strategy for immune evasion and highlights the intertwined regulation of innate immunity and autophagy, offering new directions for antiviral research.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-07-07

  The referenced study demonstrates that activation of ALDH2, a mitochondrial enzyme involved in aldehyde detoxification, significantly extends the proliferative capacity of cardiomyocytes in mice under pressure overload, delaying heart failure onset. These findings suggest a novel mechanistic approach for cardiac regeneration and present ALDH2 activators as promising research tools for studying ischemic heart disease and regeneration.

• MG-132 (Z-LLL-al): Proteasome Inhibition and Redox Regulatio

  2026-07-06

  Explore how MG-132 (Z-LLL-al) serves as a pivotal tool for dissecting proteasome function and redox regulation in cell biology. This article provides a deeper scientific perspective on MG-132’s mechanism, its impact on oxidative stress, and advanced assay considerations, distinguishing itself from standard protocol guides.

• EZ Cap EGFP mRNA 5-moUTP: Elevating mRNA Delivery Workflows

  2026-07-06

  EZ Cap™ EGFP mRNA (5-moUTP) sets a new standard for robust, immune-evasive gene expression in cell and in vivo systems. Its advanced capping, 5-methoxyuridine modification, and poly(A) tail together deliver unmatched stability and translational efficiency, making it an indispensable tool for mRNA delivery, gene function studies, and high-fidelity in vivo imaging.

• SAG Mitigates Mitochondrial Dysfunction in Frataxin-Deficien

  2026-07-05

  Vicente-Acosta et al. (2022) demonstrate that pharmacological activation of the Hedgehog pathway with the Smoothened receptor agonist SAG prevents mitochondrial dysfunction, autophagy, and neurotoxicity in frataxin-deficient human astrocytes—a model for Friedreich’s ataxia. These findings highlight a mechanistically distinct approach to modulating astrocyte reactivity and suggest potential targets for neurodegeneration research.

• Triacetin’s Role in Enhancing Aldehyde Formation in E-Cigare

  2026-07-04

  The referenced study uncovers how triacetin, a common e-cigarette additive, catalyzes the degradation of carrier solvents to significantly elevate toxic aldehyde levels in aerosols. By employing isotopic labeling and NMR spectroscopy, the authors clarify the mechanistic origin of formaldehyde, acrolein, and acetaldehyde, raising important considerations for inhalation toxicology and regulatory science.

• Carvacrol (5-Isopropyl-2-Methylphenol): Mechanisms & Researc

  2026-07-03

  Carvacrol is a monoterpene phenol (5-isopropyl-2-methylphenol) with proven antibacterial, antioxidant, and anticancer properties. Its efficacy in modulating cell cycle arrest and apoptosis is well-documented, and it serves as a benchmark reagent in redox and TRP channel research. APExBIO provides high-purity Carvacrol for advanced experimental workflows.

• Latrunculin B Inhibitor: Applied Workflows for Actin Dynamic

  2026-07-03

  Latrunculin B stands out as a transient, high-precision actin cytoskeleton disruptor, enabling reproducible manipulation of cellular actin dynamics in both basic and translational research. Learn to optimize protocols, avoid common pitfalls, and leverage new insights from virology and cell biology for advanced assay design.

• Dibutyryl-cAMP, Sodium Salt: Precision Control in Human Brai

  2026-07-02

  Explore how Dibutyryl-cAMP, sodium salt enables advanced, reproducible manipulation of cAMP signaling in complex human brain slice models. This article offers deep insights into practical assay decisions, building on recent findings that reshape our understanding of neuronal signaling.

• Enhancing Cell Assays with ARCA EGFP mRNA (5-moUTP): Practic

  2026-07-02

  This article guides biomedical researchers and lab technicians through real-world challenges in cell viability and transfection efficiency assays, showing how ARCA EGFP mRNA (5-moUTP) (SKU R1007) from APExBIO delivers reliable, evidence-backed performance. By grounding recommendations in validated data and laboratory scenarios, we demonstrate the value of polyadenylated mRNA with advanced modifications for reproducible, robust workflows.

• Cycloastragenol Inhibits Osteoclasts in Glucocorticoid-Induc

  2026-07-01

  This study demonstrates that cycloastragenol significantly reduces bone loss in a rat model of glucocorticoid-induced osteonecrosis of the femoral head (GIONFH) by inhibiting osteoclast activity. The findings clarify disease mechanisms and suggest new directions for bone-preserving interventions in steroid-associated osteonecrosis.

• MK 0893: Deep Mechanistic Insights and Protocol Optimization

  2026-07-01

  Explore how MK 0893, a potent glucagon receptor antagonist, enables advanced mechanistic studies and protocol optimization in type 2 diabetes research. This article uncovers unique assay strategies and translational applications not found elsewhere.

453 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page